Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transdermal Skin Patch Market Growth 2022-2028

  • LP 4862607
  • 101 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transdermal Skin Patch will have significant change from previous year. According to our (LP Information) latest study, the global Transdermal Skin Patch market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Transdermal Skin Patch market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Transdermal Skin Patch market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transdermal Skin Patch market, reaching US$ million by the year 2028. As for the Europe Transdermal Skin Patch landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transdermal Skin Patch players cover Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, and Teikoku Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Skin Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Fentanyl Transdermal Skin Patch

Nicotine Transdermal Skin Patch

Clonidine Transdermal Skin Patch

Buprenorphine Transdermal Skin Patch

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Relieve Severe Pain

Stop Smoking Cigarettes

Treat an Overactive Bladder

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Hisamitsu Pharmaceutical

Novartis

Johnson & Johnson

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

Luye Pharma Group Ltd.

Purdue Pharma L.P.

Teva Pharmaceutical Industries Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transdermal Skin Patch Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Transdermal Skin Patch by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Transdermal Skin Patch by Country/Region, 2017, 2022 & 2028

2.2 Transdermal Skin Patch Segment by Type

2.2.1 Fentanyl Transdermal Skin Patch

2.2.2 Nicotine Transdermal Skin Patch

2.2.3 Clonidine Transdermal Skin Patch

2.2.4 Buprenorphine Transdermal Skin Patch

2.3 Transdermal Skin Patch Sales by Type

2.3.1 Global Transdermal Skin Patch Sales Market Share by Type (2017-2022)

2.3.2 Global Transdermal Skin Patch Revenue and Market Share by Type (2017-2022)

2.3.3 Global Transdermal Skin Patch Sale Price by Type (2017-2022)

2.4 Transdermal Skin Patch Segment by Application

2.4.1 Relieve Severe Pain

2.4.2 Stop Smoking Cigarettes

2.4.3 Treat an Overactive Bladder

2.4.4 Others

2.5 Transdermal Skin Patch Sales by Application

2.5.1 Global Transdermal Skin Patch Sale Market Share by Application (2017-2022)

2.5.2 Global Transdermal Skin Patch Revenue and Market Share by Application (2017-2022)

2.5.3 Global Transdermal Skin Patch Sale Price by Application (2017-2022)

3 Global Transdermal Skin Patch by Company

3.1 Global Transdermal Skin Patch Breakdown Data by Company

3.1.1 Global Transdermal Skin Patch Annual Sales by Company (2020-2022)

3.1.2 Global Transdermal Skin Patch Sales Market Share by Company (2020-2022)

3.2 Global Transdermal Skin Patch Annual Revenue by Company (2020-2022)

3.2.1 Global Transdermal Skin Patch Revenue by Company (2020-2022)

3.2.2 Global Transdermal Skin Patch Revenue Market Share by Company (2020-2022)

3.3 Global Transdermal Skin Patch Sale Price by Company

3.4 Key Manufacturers Transdermal Skin Patch Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transdermal Skin Patch Product Location Distribution

3.4.2 Players Transdermal Skin Patch Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Transdermal Skin Patch by Geographic Region

4.1 World Historic Transdermal Skin Patch Market Size by Geographic Region (2017-2022)

4.1.1 Global Transdermal Skin Patch Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Transdermal Skin Patch Annual Revenue by Geographic Region

4.2 World Historic Transdermal Skin Patch Market Size by Country/Region (2017-2022)

4.2.1 Global Transdermal Skin Patch Annual Sales by Country/Region (2017-2022)

4.2.2 Global Transdermal Skin Patch Annual Revenue by Country/Region

4.3 Americas Transdermal Skin Patch Sales Growth

4.4 APAC Transdermal Skin Patch Sales Growth

4.5 Europe Transdermal Skin Patch Sales Growth

4.6 Middle East & Africa Transdermal Skin Patch Sales Growth

5 Americas

5.1 Americas Transdermal Skin Patch Sales by Country

5.1.1 Americas Transdermal Skin Patch Sales by Country (2017-2022)

5.1.2 Americas Transdermal Skin Patch Revenue by Country (2017-2022)

5.2 Americas Transdermal Skin Patch Sales by Type

5.3 Americas Transdermal Skin Patch Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transdermal Skin Patch Sales by Region

6.1.1 APAC Transdermal Skin Patch Sales by Region (2017-2022)

6.1.2 APAC Transdermal Skin Patch Revenue by Region (2017-2022)

6.2 APAC Transdermal Skin Patch Sales by Type

6.3 APAC Transdermal Skin Patch Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Transdermal Skin Patch by Country

7.1.1 Europe Transdermal Skin Patch Sales by Country (2017-2022)

7.1.2 Europe Transdermal Skin Patch Revenue by Country (2017-2022)

7.2 Europe Transdermal Skin Patch Sales by Type

7.3 Europe Transdermal Skin Patch Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transdermal Skin Patch by Country

8.1.1 Middle East & Africa Transdermal Skin Patch Sales by Country (2017-2022)

8.1.2 Middle East & Africa Transdermal Skin Patch Revenue by Country (2017-2022)

8.2 Middle East & Africa Transdermal Skin Patch Sales by Type

8.3 Middle East & Africa Transdermal Skin Patch Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Transdermal Skin Patch

10.3 Manufacturing Process Analysis of Transdermal Skin Patch

10.4 Industry Chain Structure of Transdermal Skin Patch

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Transdermal Skin Patch Distributors

11.3 Transdermal Skin Patch Customer

12 World Forecast Review for Transdermal Skin Patch by Geographic Region

12.1 Global Transdermal Skin Patch Market Size Forecast by Region

12.1.1 Global Transdermal Skin Patch Forecast by Region (2023-2028)

12.1.2 Global Transdermal Skin Patch Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Transdermal Skin Patch Forecast by Type

12.7 Global Transdermal Skin Patch Forecast by Application

13 Key Players Analysis

13.1 Hisamitsu Pharmaceutical

13.1.1 Hisamitsu Pharmaceutical Company Information

13.1.2 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Offered

13.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Hisamitsu Pharmaceutical Main Business Overview

13.1.5 Hisamitsu Pharmaceutical Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Transdermal Skin Patch Product Offered

13.2.3 Novartis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Company Information

13.3.2 Johnson & Johnson Transdermal Skin Patch Product Offered

13.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Johnson & Johnson Main Business Overview

13.3.5 Johnson & Johnson Latest Developments

13.4 Teikoku Pharma

13.4.1 Teikoku Pharma Company Information

13.4.2 Teikoku Pharma Transdermal Skin Patch Product Offered

13.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teikoku Pharma Main Business Overview

13.4.5 Teikoku Pharma Latest Developments

13.5 Mylan

13.5.1 Mylan Company Information

13.5.2 Mylan Transdermal Skin Patch Product Offered

13.5.3 Mylan Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Mylan Main Business Overview

13.5.5 Mylan Latest Developments

13.6 Actavis

13.6.1 Actavis Company Information

13.6.2 Actavis Transdermal Skin Patch Product Offered

13.6.3 Actavis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Actavis Main Business Overview

13.6.5 Actavis Latest Developments

13.7 Mundipharma

13.7.1 Mundipharma Company Information

13.7.2 Mundipharma Transdermal Skin Patch Product Offered

13.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mundipharma Main Business Overview

13.7.5 Mundipharma Latest Developments

13.8 Henan Lingrui Pharmaceutical

13.8.1 Henan Lingrui Pharmaceutical Company Information

13.8.2 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Offered

13.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Henan Lingrui Pharmaceutical Main Business Overview

13.8.5 Henan Lingrui Pharmaceutical Latest Developments

13.9 Changzhou Siyao

13.9.1 Changzhou Siyao Company Information

13.9.2 Changzhou Siyao Transdermal Skin Patch Product Offered

13.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Changzhou Siyao Main Business Overview

13.9.5 Changzhou Siyao Latest Developments

13.10 Rfl Pharmaceutical

13.10.1 Rfl Pharmaceutical Company Information

13.10.2 Rfl Pharmaceutical Transdermal Skin Patch Product Offered

13.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Rfl Pharmaceutical Main Business Overview

13.10.5 Rfl Pharmaceutical Latest Developments

13.11 Luye Pharma Group Ltd.

13.11.1 Luye Pharma Group Ltd. Company Information

13.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Product Offered

13.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Luye Pharma Group Ltd. Main Business Overview

13.11.5 Luye Pharma Group Ltd. Latest Developments

13.12 Purdue Pharma L.P.

13.12.1 Purdue Pharma L.P. Company Information

13.12.2 Purdue Pharma L.P. Transdermal Skin Patch Product Offered

13.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Purdue Pharma L.P. Main Business Overview

13.12.5 Purdue Pharma L.P. Latest Developments

13.13 Teva Pharmaceutical Industries Ltd.

13.13.1 Teva Pharmaceutical Industries Ltd. Company Information

13.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Offered

13.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Transdermal Skin Patch Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Transdermal Skin Patch Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Fentanyl Transdermal Skin Patch

Table 4. Major Players of Nicotine Transdermal Skin Patch

Table 5. Major Players of Clonidine Transdermal Skin Patch

Table 6. Major Players of Buprenorphine Transdermal Skin Patch

Table 7. Global Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)

Table 8. Global Transdermal Skin Patch Sales Market Share by Type (2017-2022)

Table 9. Global Transdermal Skin Patch Revenue by Type (2017-2022) & ($ million)

Table 10. Global Transdermal Skin Patch Revenue Market Share by Type (2017-2022)

Table 11. Global Transdermal Skin Patch Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)

Table 13. Global Transdermal Skin Patch Sales Market Share by Application (2017-2022)

Table 14. Global Transdermal Skin Patch Revenue by Application (2017-2022)

Table 15. Global Transdermal Skin Patch Revenue Market Share by Application (2017-2022)

Table 16. Global Transdermal Skin Patch Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Transdermal Skin Patch Sales by Company (2020-2022) & (K Units)

Table 18. Global Transdermal Skin Patch Sales Market Share by Company (2020-2022)

Table 19. Global Transdermal Skin Patch Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Transdermal Skin Patch Revenue Market Share by Company (2020-2022)

Table 21. Global Transdermal Skin Patch Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Transdermal Skin Patch Producing Area Distribution and Sales Area

Table 23. Players Transdermal Skin Patch Products Offered

Table 24. Transdermal Skin Patch Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Transdermal Skin Patch Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Transdermal Skin Patch Sales Market Share Geographic Region (2017-2022)

Table 29. Global Transdermal Skin Patch Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Transdermal Skin Patch Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Transdermal Skin Patch Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Transdermal Skin Patch Sales Market Share by Country/Region (2017-2022)

Table 33. Global Transdermal Skin Patch Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Transdermal Skin Patch Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Transdermal Skin Patch Sales by Country (2017-2022) & (K Units)

Table 36. Americas Transdermal Skin Patch Sales Market Share by Country (2017-2022)

Table 37. Americas Transdermal Skin Patch Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Transdermal Skin Patch Revenue Market Share by Country (2017-2022)

Table 39. Americas Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)

Table 40. Americas Transdermal Skin Patch Sales Market Share by Type (2017-2022)

Table 41. Americas Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)

Table 42. Americas Transdermal Skin Patch Sales Market Share by Application (2017-2022)

Table 43. APAC Transdermal Skin Patch Sales by Region (2017-2022) & (K Units)

Table 44. APAC Transdermal Skin Patch Sales Market Share by Region (2017-2022)

Table 45. APAC Transdermal Skin Patch Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Transdermal Skin Patch Revenue Market Share by Region (2017-2022)

Table 47. APAC Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)

Table 48. APAC Transdermal Skin Patch Sales Market Share by Type (2017-2022)

Table 49. APAC Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)

Table 50. APAC Transdermal Skin Patch Sales Market Share by Application (2017-2022)

Table 51. Europe Transdermal Skin Patch Sales by Country (2017-2022) & (K Units)

Table 52. Europe Transdermal Skin Patch Sales Market Share by Country (2017-2022)

Table 53. Europe Transdermal Skin Patch Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Transdermal Skin Patch Revenue Market Share by Country (2017-2022)

Table 55. Europe Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)

Table 56. Europe Transdermal Skin Patch Sales Market Share by Type (2017-2022)

Table 57. Europe Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)

Table 58. Europe Transdermal Skin Patch Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Transdermal Skin Patch Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Transdermal Skin Patch Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Transdermal Skin Patch Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Transdermal Skin Patch Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Transdermal Skin Patch Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Transdermal Skin Patch Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Transdermal Skin Patch

Table 68. Key Market Challenges & Risks of Transdermal Skin Patch

Table 69. Key Industry Trends of Transdermal Skin Patch

Table 70. Transdermal Skin Patch Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Transdermal Skin Patch Distributors List

Table 73. Transdermal Skin Patch Customer List

Table 74. Global Transdermal Skin Patch Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Transdermal Skin Patch Sales Market Forecast by Region

Table 76. Global Transdermal Skin Patch Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Transdermal Skin Patch Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Transdermal Skin Patch Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Transdermal Skin Patch Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Transdermal Skin Patch Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Transdermal Skin Patch Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Transdermal Skin Patch Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Transdermal Skin Patch Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Transdermal Skin Patch Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Transdermal Skin Patch Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Transdermal Skin Patch Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Transdermal Skin Patch Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Transdermal Skin Patch Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Transdermal Skin Patch Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Transdermal Skin Patch Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Transdermal Skin Patch Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Transdermal Skin Patch Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Transdermal Skin Patch Revenue Market Share Forecast by Application (2023-2028)

Table 94. Hisamitsu Pharmaceutical Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 95. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Offered

Table 96. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Hisamitsu Pharmaceutical Main Business

Table 98. Hisamitsu Pharmaceutical Latest Developments

Table 99. Novartis Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 100. Novartis Transdermal Skin Patch Product Offered

Table 101. Novartis Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Novartis Main Business

Table 103. Novartis Latest Developments

Table 104. Johnson & Johnson Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 105. Johnson & Johnson Transdermal Skin Patch Product Offered

Table 106. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Johnson & Johnson Main Business

Table 108. Johnson & Johnson Latest Developments

Table 109. Teikoku Pharma Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 110. Teikoku Pharma Transdermal Skin Patch Product Offered

Table 111. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Teikoku Pharma Main Business

Table 113. Teikoku Pharma Latest Developments

Table 114. Mylan Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 115. Mylan Transdermal Skin Patch Product Offered

Table 116. Mylan Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Mylan Main Business

Table 118. Mylan Latest Developments

Table 119. Actavis Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 120. Actavis Transdermal Skin Patch Product Offered

Table 121. Actavis Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. Actavis Main Business

Table 123. Actavis Latest Developments

Table 124. Mundipharma Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 125. Mundipharma Transdermal Skin Patch Product Offered

Table 126. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Mundipharma Main Business

Table 128. Mundipharma Latest Developments

Table 129. Henan Lingrui Pharmaceutical Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 130. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Offered

Table 131. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Henan Lingrui Pharmaceutical Main Business

Table 133. Henan Lingrui Pharmaceutical Latest Developments

Table 134. Changzhou Siyao Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 135. Changzhou Siyao Transdermal Skin Patch Product Offered

Table 136. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. Changzhou Siyao Main Business

Table 138. Changzhou Siyao Latest Developments

Table 139. Rfl Pharmaceutical Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 140. Rfl Pharmaceutical Transdermal Skin Patch Product Offered

Table 141. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Rfl Pharmaceutical Main Business

Table 143. Rfl Pharmaceutical Latest Developments

Table 144. Luye Pharma Group Ltd. Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 145. Luye Pharma Group Ltd. Transdermal Skin Patch Product Offered

Table 146. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Luye Pharma Group Ltd. Main Business

Table 148. Luye Pharma Group Ltd. Latest Developments

Table 149. Purdue Pharma L.P. Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 150. Purdue Pharma L.P. Transdermal Skin Patch Product Offered

Table 151. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Purdue Pharma L.P. Main Business

Table 153. Purdue Pharma L.P. Latest Developments

Table 154. Teva Pharmaceutical Industries Ltd. Basic Information, Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors

Table 155. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Offered

Table 156. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 157. Teva Pharmaceutical Industries Ltd. Main Business

Table 158. Teva Pharmaceutical Industries Ltd. Latest Developments

List of Figures

Figure 1. Picture of Transdermal Skin Patch

Figure 2. Transdermal Skin Patch Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transdermal Skin Patch Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Transdermal Skin Patch Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Transdermal Skin Patch Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Fentanyl Transdermal Skin Patch

Figure 10. Product Picture of Nicotine Transdermal Skin Patch

Figure 11. Product Picture of Clonidine Transdermal Skin Patch

Figure 12. Product Picture of Buprenorphine Transdermal Skin Patch

Figure 13. Global Transdermal Skin Patch Sales Market Share by Type in 2021

Figure 14. Global Transdermal Skin Patch Revenue Market Share by Type (2017-2022)

Figure 15. Transdermal Skin Patch Consumed in Relieve Severe Pain

Figure 16. Global Transdermal Skin Patch Market: Relieve Severe Pain (2017-2022) & (K Units)

Figure 17. Transdermal Skin Patch Consumed in Stop Smoking Cigarettes

Figure 18. Global Transdermal Skin Patch Market: Stop Smoking Cigarettes (2017-2022) & (K Units)

Figure 19. Transdermal Skin Patch Consumed in Treat an Overactive Bladder

Figure 20. Global Transdermal Skin Patch Market: Treat an Overactive Bladder (2017-2022) & (K Units)

Figure 21. Transdermal Skin Patch Consumed in Others

Figure 22. Global Transdermal Skin Patch Market: Others (2017-2022) & (K Units)

Figure 23. Global Transdermal Skin Patch Sales Market Share by Application (2017-2022)

Figure 24. Global Transdermal Skin Patch Revenue Market Share by Application in 2021

Figure 25. Transdermal Skin Patch Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Transdermal Skin Patch Revenue Market Share by Company in 2021

Figure 27. Global Transdermal Skin Patch Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Transdermal Skin Patch Revenue Market Share by Geographic Region in 2021

Figure 29. Global Transdermal Skin Patch Sales Market Share by Region (2017-2022)

Figure 30. Global Transdermal Skin Patch Revenue Market Share by Country/Region in 2021

Figure 31. Americas Transdermal Skin Patch Sales 2017-2022 (K Units)

Figure 32. Americas Transdermal Skin Patch Revenue 2017-2022 ($ Millions)

Figure 33. APAC Transdermal Skin Patch Sales 2017-2022 (K Units)

Figure 34. APAC Transdermal Skin Patch Revenue 2017-2022 ($ Millions)

Figure 35. Europe Transdermal Skin Patch Sales 2017-2022 (K Units)

Figure 36. Europe Transdermal Skin Patch Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Transdermal Skin Patch Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Transdermal Skin Patch Revenue 2017-2022 ($ Millions)

Figure 39. Americas Transdermal Skin Patch Sales Market Share by Country in 2021

Figure 40. Americas Transdermal Skin Patch Revenue Market Share by Country in 2021

Figure 41. United States Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Transdermal Skin Patch Sales Market Share by Region in 2021

Figure 46. APAC Transdermal Skin Patch Revenue Market Share by Regions in 2021

Figure 47. China Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Transdermal Skin Patch Sales Market Share by Country in 2021

Figure 54. Europe Transdermal Skin Patch Revenue Market Share by Country in 2021

Figure 55. Germany Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Transdermal Skin Patch Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Transdermal Skin Patch Revenue Market Share by Country in 2021

Figure 62. Egypt Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Transdermal Skin Patch Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Transdermal Skin Patch in 2021

Figure 68. Manufacturing Process Analysis of Transdermal Skin Patch

Figure 69. Industry Chain Structure of Transdermal Skin Patch

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390